Quick Overview:
Amaryl M1 Forte delivers dual-action therapeutic control. Glimepiride acts as an insulin secretagogue by stimulating the pancreatic beta cells to release more insulin. Metformin works by suppressing hepatic glucose production (gluconeogenesis), slowing glucose absorption in the intestines, and augmenting peripheral insulin sensitivity. The "Forte" designation indicates a higher strength of prolonged-release Metformin (1000 mg instead of the standard 500 mg) to offer sustained blood glucose control over a longer duration
No description available.
Uses / Indications
Management of Type 2 Diabetes mellitus in adults. Controlling glycemic spikes when monotherapy (metformin or glimepiride alone) paired with diet and exercise fails to provide adequate control.
Key Benefits
Optimizes long-term blood glucose regulation via a synergistic approach. Prolonged-release formulation ensures smooth drug delivery and minimizes sudden blood sugar drops. Significantly decreases the risks of diabetes-related macrovascular and microvascular complications, including nephropathy, retinopathy, neuropathy, and limb loss.
As directed by the physician. Typically taken orally once daily with breakfast or the first main meal of the day. Tablets must be swallowed whole with water and should not be crushed, broken, or chewed to preserve the prolonged-release mechanism.
Common: Hypoglycemia (low blood sugar levels marked by sweating, dizziness, shakiness, and headache), nausea, vomiting, diarrhea, abdominal distress, temporary altered taste, and upper respiratory tract infections.
Severe/Rare: Lactic acidosis (a medical emergency characterized by deep rapid breathing, muscle pain, and severe drowsiness), long-term Vitamin B12 deficiency, severe liver dysfunction (jaundice), and hypersensitivity skin reactions (e.g., Stevens-Johnson syndrome)
- Store in a cool dry place
- Keep away from direct sunlight
- Keep out of reach of children
- Read the label carefully before use
